Bioinformatics analysis reveals four major hexon variants of human adenovirus type-3 (HAdV-3) as the potential strains for development of vaccine and siRNA-based therapeutics against HAdV-3 respiratory infections

Human adenovirus type 3 (HAdV-3) encompasses 15–87% of all adenoviral respiratory infections. The significant morbidity and mortality, especially among the neonates and immunosuppressed patients, demand the need for a vaccine or a targeted antiviral against this type. However, due to the existence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Panda, Somnath, Banik, Urmila, Adhikary, Arun K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308778/
https://www.ncbi.nlm.nih.gov/pubmed/32585339
http://dx.doi.org/10.1016/j.meegid.2020.104439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308778/
https://www.ncbi.nlm.nih.gov/pubmed/32585339
http://dx.doi.org/10.1016/j.meegid.2020.104439

Ejemplares similares